These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 11088030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
    Guo H, Zhu H, Xi Y, Zhang B, Li L, Huang Y, Zhang J, Fu Z, Yang G, Yuan S, Yu J.
    J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 5. Does FDG-PET add information to EUS and CT in the initial management of esophageal cancer? A prospective single center study.
    McDonough PB, Jones DR, Shen KR, Northup PG, Galysh RL, Hernandez A, White GE, Kahaleh M, Shami VM.
    Am J Gastroenterol; 2008 Mar; 103(3):570-4. PubMed ID: 17941963
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.
    Jerusalem G, Beguin Y, Fassotte MF, Najjar F, Paulus P, Rigo P, Fillet G.
    Haematologica; 2001 Mar; 86(3):266-73. PubMed ID: 11255273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
    Lee JH, Park SG, Jee KN, Park DG, Namgung H, Song IH.
    Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
    Di Martino E, Hausmann R, Krombach GA, Nowak B, Tietze L, Gagel B, Zimny M, Westhofen M.
    Laryngorhinootologie; 2002 Dec; 81(12):866-74. PubMed ID: 12486624
    [Abstract] [Full Text] [Related]

  • 14. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma.
    Mertz HR, Sechopoulos P, Delbeke D, Leach SD.
    Gastrointest Endosc; 2000 Sep; 52(3):367-71. PubMed ID: 10968852
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
    Kyoto Y, Momose M, Kondo C, Itabashi M, Kameoka S, Kusakabe K.
    Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373
    [Abstract] [Full Text] [Related]

  • 17. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
    Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K.
    Cancer; 2013 Mar 15; 119(6):1227-34. PubMed ID: 23233156
    [Abstract] [Full Text] [Related]

  • 18. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
    Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L.
    J Clin Oncol; 2000 Sep 15; 18(18):3202-10. PubMed ID: 10986052
    [Abstract] [Full Text] [Related]

  • 19. Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma.
    Purandare NC, Pramesh CS, Karimundackal G, Jiwnani S, Agrawal A, Shah S, Kulkarni M, Laskar SG, Rangarajan V.
    Nucl Med Commun; 2014 Aug 15; 35(8):864-9. PubMed ID: 24751701
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of esophageal cancer during the pretreatment of hypopharyngeal cancer patients: routinely performed esophagogastroduodenoscopy and FDG-PET/CT findings.
    Nakaminato S, Toriihara A, Makino T, Kawano T, Kishimoto S, Shibuya H.
    Acta Oncol; 2012 May 15; 51(5):645-52. PubMed ID: 22229748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.